Kezar Life Sciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.

About KZR

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. 

CEO
John Fowler
CEOJohn Fowler
Employees
56
Employees56
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2015
Founded2015
Employees
56
Employees56

KZR Key Statistics

Market cap
576.36M
Market cap576.36M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.66M
Average volume1.66M
High today
$8.46
High today$8.46
Low today
$8.00
Low today$8.00
Open price
$8.15
Open price$8.15
Volume
2.01M
Volume2.01M
52 Week high
$18.55
52 Week high$18.55
52 Week low
$4.31
52 Week low$4.31

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

KZR Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, After Hours
ActualExpected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.